What does Viridian Therapeutics, Inc.DE (VRDN) do?

Viridian Therapeutics, Inc.DE (VRDN) is a publicly traded company in the Healthcare sector.

What sector does VRDN operate in?

Viridian Therapeutics, Inc.DE operates in the Healthcare, specifically within the Pharmaceuticals industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find VRDN earnings analysis?

AlphaOS publishes an earnings intelligence page for Viridian Therapeutics, Inc.DE (VRDN) covering results, guidance context, and AI-assisted analysis. See /stocks/VRDN/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 70%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

VRDN

Viridian Therapeutics, Inc.DE

Healthcare · Pharmaceuticals

$20.00Sep 29, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Viridian Therapeutics, Inc.DE shows accelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +279% YoY in Q2 FY2026.

TrajectoryAccelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue +279% YoY in Q2 FY2026

Pipeline evidence · 0d ago

VRDN's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on VRDN.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full VRDN earnings analysis

Reported figures for Viridian Therapeutics, Inc.DE — research only, not investment advice.

Revenue YoY: +278.7%

Latest Intelligence

Updated September 30, 2026

What happened recently for Viridian Therapeutics, Inc.DE (VRDN) — events, not interpretation.

Event: Reported Q2 2026 revenue +279% YoY.
Also: Last session September 29, 2026 at $20.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Viridian Therapeutics, Inc.DE (VRDN)

Healthcare · Pharmaceuticals

Investment Snapshot above is the primary AlphaOS analysis for Viridian Therapeutics, Inc.DE — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Pharmaceuticals
Market cap:: $2.27B
Revenue:: $5.71M

VRDN earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Viridian Therapeutics, Inc.DE through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Related & Connected

Connected companies and research pages from the AlphaOS knowledge graph.